Imvax: Latest News, Top Stories & Analysis

PHILADELPHIA, PA — Imvax, Inc. is set to highlight its innovative research on glioblastoma treatment at the 2024 Society for NeuroOncology (SNO) Annual Meeting in Houston, Texas, from November 21-24. …

Regional

Imvax Completes Enrollment for Phase 2b Trial of Innovative Glioblastoma Treatment

May 28, 2024May 27, 2024 - by Timothy Alexander

PHILADELPHIA, PA — Imvax, Inc. has announced the completion of enrollment in its Phase 2b clinical trial of IGV-001, a novel treatment for newly diagnosed glioblastoma (ndGBM). The trial, which …